1. Role and regulation of FOXO3a: new insights into breast cancer therapy
   Wenqiu Mei et al, 2024, Frontiers in Pharmacology CrossRef
2. Relevance of Membrane Contact Sites in Cancer Progression
   Aurora Gil-Hernández et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
3. Establishment of an orthotopic tumor model in the mammary gland of BALB/C nude mice using human breast cancer MCF-7 cells and their VDAC-deficient derivatives
   E. Yu. Mndlyan et al, 2022, Siberian journal of oncology CrossRef
4. VDAC Modulation of Cancer Metabolism: Advances and Therapeutic Challenges
   Kareem A. Heslop et al, 2021, Frontiers in Physiology CrossRef
5. BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells
   Teresa Rossi et al, 2024, Cell Proliferation CrossRef
6. Pore-Forming VDAC Proteins of the Outer Mitochondrial Membrane: Regulation and Pathophysiological Role
   Natalia V. Belosludtseva et al, 2024, Biochemistry (Moscow) CrossRef
7. Effects of arginine on coenzyme-Q10 micelle uptake for mitochondria-targeted nanotherapy in phenylketonuria
   Burcu Uner et al, 2024, Drug Delivery and Translational Research CrossRef
8. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
   Yutong Fang et al, 2022, World Journal of Surgical Oncology CrossRef
9. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
   Teresa Rossi et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef